Tetracycline-controlled transcription in eukaryotes: Novel transactivators with graded transactivation potential

294Citations
Citations of this article
245Readers
Mendeley users who have this article in their library.

Abstract

Several tetracycline-controlled transactivators (tTA) were generated which differ in their activation potential by > 3 orders of magnitude. The transactivators are fusions between the Tet repressor and minimal transcriptional activation domains derived from Herpes simplex virus protein 16 (VP16). By reducing the VP16 moiety of the previously described tTA to 12 amino acids, potential targets for interactions with various cellular transcription factors were eliminated, as were potential epitopes which may elicit a cellular immune response. When compared with the originally described tTA, these new transactivators are tolerated at higher intracellular concentrations. This will facilitate establishment of tet regulatory systems under a variety of conditions, but particularly when cell type-restricted tetracycline-controlled gene expression is to be achieved in transgenic organisms via homologous recombination.

Cite

CITATION STYLE

APA

Baron, U., Gossen, M., & Bujard, H. (1997). Tetracycline-controlled transcription in eukaryotes: Novel transactivators with graded transactivation potential. Nucleic Acids Research, 25(14), 2723–2729. https://doi.org/10.1093/nar/25.14.2723

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free